These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 32502983)

  • 81. Metabolic Resolution of Lytic Lesions in Erdheim-Chester Disease on 18F-FDG PET/CT.
    Yadav D; Seth R; Shamim SA; Kumar R
    Clin Nucl Med; 2020 Dec; 45(12):e514-e515. PubMed ID: 32604106
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Erdheim-Chester Disease Due to a Novel Internal Duplication of NRAS: Response to Targeted Therapy with Cobimetinib.
    Riancho JA; Hernández JL; González-Vela C; López-Sundh AE; González-Lopez MA; Gomez de la Fuente F; Quirce R; Diamond EL
    Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37895147
    [TBL] [Abstract][Full Text] [Related]  

  • 83. BRAFV600E-mutation is invariably present and associated to oncogene-induced senescence in Erdheim-Chester disease.
    Cangi MG; Biavasco R; Cavalli G; Grassini G; Dal-Cin E; Campochiaro C; Guglielmi B; Berti A; Lampasona V; von Deimling A; Sabbadini MG; Ferrarini M; Doglioni C; Dagna L
    Ann Rheum Dis; 2015 Aug; 74(8):1596-602. PubMed ID: 24671772
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Intracranial mass lesions and skin discoloration in the armpits as unusual clues to Erdheim-Chester disease: a case report.
    Rodrigues PGB; Pereira IS; Lima Filho VB; Dias DA; Nóbrega PR; Braga-Neto P
    BMC Neurol; 2021 Feb; 21(1):81. PubMed ID: 33602153
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Erdheim-Chester disease: a comprehensive review.
    Abdelfattah AM; Arnaout K; Tabbara IA
    Anticancer Res; 2014 Jul; 34(7):3257-61. PubMed ID: 24982329
    [TBL] [Abstract][Full Text] [Related]  

  • 86. [Langerhans cell histiocytosis and Erdheim-Chester disease, a continuity?].
    Parreau S; Haroche J; Pommepuy I; Emile JF; Bourras JC; Archambeaud F
    Rev Med Interne; 2017 Jul; 38(7):482-487. PubMed ID: 27889325
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Multimodality imaging showing complete cardiovascular involvement by Erdheim-Chester disease.
    Alharthi MS; Calleja A; Panse P; Appleton C; Jaroszewski DE; Tazelaar HD; Mookadam F
    Eur J Echocardiogr; 2010 Aug; 11(7):E25. PubMed ID: 20406735
    [TBL] [Abstract][Full Text] [Related]  

  • 88. [Evaluation of five years of treatment of Erdheim-Chester disease with anakinra: case report and overview of literature].
    Adam Z; Petrášová H; Řehák Z; Koukalová R; Krejčí M; Pour L; Vetešníková E; Čermák A; Ševčíková S; Szturz P; Král Z; Mayer J
    Vnitr Lek; 2016; 62(10):820-832. PubMed ID: 27900869
    [TBL] [Abstract][Full Text] [Related]  

  • 89. FDG PET/CT Findings of Erdheim-Chester Disease: Radiologic Response to a Novel Treatment Regimen.
    Akin EA; Osman M; Ellenbogen AL
    Clin Nucl Med; 2018 May; 43(5):337-340. PubMed ID: 29485431
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Uncommon histiocytic disorders: Rosai-Dorfman, juvenile xanthogranuloma, and Erdheim-Chester disease.
    Haroche J; Abla O
    Hematology Am Soc Hematol Educ Program; 2015; 2015():571-8. PubMed ID: 26637774
    [TBL] [Abstract][Full Text] [Related]  

  • 91. [Erdheim-Chester disease presenting with bilateral orbital involvement: Report of three cases].
    Kiratli H; Koç I; Söylemezoğlu F
    J Fr Ophtalmol; 2020 Nov; 43(9):851-857. PubMed ID: 32829941
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Unusually long-term responses to vemurafenib in BRAF V600E mutated colon and thyroid cancers followed by the development of rare RAS activating mutations.
    Ofir Dovrat T; Sokol E; Frampton G; Shachar E; Pelles S; Geva R; Wolf I
    Cancer Biol Ther; 2018; 19(10):871-874. PubMed ID: 30036146
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Erdheim-Chester Disease With Cardiovascular Involvement and BRAF V600E Mutation.
    Okamura K; Suematsu Y; Morizumi S; Kawata M; Dai Y; Yamakawa M; Ono M
    Circ J; 2016 Jun; 80(7):1657-9. PubMed ID: 27296272
    [No Abstract]   [Full Text] [Related]  

  • 94. Erdheim-Chester disease (ECD): Case report, clinical and basic investigations, and review of literature.
    Adawi M; Bisharat B; Bowirrat A
    Medicine (Baltimore); 2016 Oct; 95(42):e5167. PubMed ID: 27759649
    [TBL] [Abstract][Full Text] [Related]  

  • 95. [Erdheim-Chester disease: a non-Langerhans cell histiocytosis. A clinical-case and review of the literature].
    Valentini D; Cappelli C; Mizzoni F; Noto C; Toscano D; Foco M; Trasimeni G
    Clin Ter; 2004 May; 155(5):205-8. PubMed ID: 15344569
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Erdheim Chester disease in a patient with Burkitt lymphoma: a case report and review of literature.
    Sakr HI; Buckley K; Baiocchi R; Zhao WJ; Hemminger JA
    Diagn Pathol; 2018 Nov; 13(1):94. PubMed ID: 30474563
    [TBL] [Abstract][Full Text] [Related]  

  • 97. [Erdheim-Chester disease].
    Mazor RD; Shoenfeld Y
    Harefuah; 2014 Jul; 153(7):389-91, 434, 433. PubMed ID: 25189027
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Cardiothoracic manifestations of Erdheim-Chester disease.
    Das JP; Xie L; Riedl CC; Hayes SA; Ginsberg MS; Halpenny DF
    Br J Radiol; 2019 Dec; 92(1104):20190473. PubMed ID: 31386554
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Erdheim-Chester Disease With BRAF V600E Mutation and Central Diabetes Insipidus Successfully Treated With Glucocorticoid.
    Imaizumi T; Daido H; Kato T; Yabe D
    JCEM Case Rep; 2023 Mar; 1(2):luad014. PubMed ID: 37908458
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Histiocytic disorders: insights into novel biology and implications for therapy of Langerhans cell histiocytosis and Erdheim-Chester disease.
    McClain K
    Hematology Am Soc Hematol Educ Program; 2020 Dec; 2020(1):395-399. PubMed ID: 33275721
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.